A pilot study of hormone modulation as a new treatment for mania in women with bipolar affective disorder

Psychoneuroendocrinology

Volumn 31, Issue 4, 2006, Pages 543-547

  Kulkarni, Jayashri ^a,b   Garland, Kathryn A ^a,b   Scaffidi, Antonietta ^a   Headey, Barbara ^a   Anderson, Robyn ^a   Castella, Anthony De ^a,b   Fitzgerald, Paul ^a,b   Davis, Susan R ^a,b  

^a ALFRED HOSPITAL   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Bipolar affective disorder; Mania; Medroxyprogesterone acetate; Tamoxifen; Women

Indexed keywords

MEDROXYPROGESTERONE ACETATE; PLACEBO; PROGESTERONE; TAMOXIFEN;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BIPOLAR DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPOMANIA; PRIORITY JOURNAL;

ACUTE DISEASE; ADULT; ANALYSIS OF VARIANCE; ANTIMANIC AGENTS; BIPOLAR DISORDER; DOUBLE-BLIND METHOD; ESTRADIOL; ESTROGEN ANTAGONISTS; FEMALE; HUMANS; MEDROXYPROGESTERONE; MIDDLE AGED; PILOT PROJECTS; PROGESTERONE CONGENERS; PSYCHIATRIC STATUS RATING SCALES; STATISTICS, NONPARAMETRIC; TAMOXIFEN; TREATMENT OUTCOME;

EID: 33644872106     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2005.11.001     Document Type: Article

References (15)

1. E.G. Altman, D.R. Hedeker, P.G. Janicak, J.L. Peterson, and J.M. Davis The Clinician-Administered Rating Scale for Mania (CARS-M): development, reliability and validity Biol. Psychiatry 36 2 1994 124 134
2. J.M. Bebchuk, C.L. Arfken, S. Dolan-Manji, J. Murphy, K. Hasanat, and H.K. Manji A preliminary investigation of a protein kinase C inhibitor in the treatment of acute mania Arch. Gen. Psychiatry 57 2000 95 97
3. J.C. Chou Recent advances in treatment of acute mania J. Clin. Psychopharmacol. 11 1991 3 21
4. G. Chouinard, S. Steinberg, and W. Steiner Estrogen-progesterone combination: another mood stabilizer? (letter) Am. J. Psychiatry 144 1987 826
5. B. Corbella, and E. Vieta Molecular targets of lithium action Acta Neuropsychiatrica 15 2003 316 340
6. First, M.B., Spitzer, R.L., Gibbon, M., Williams, J.B.W., 1994. Structured clinical interview for DSM-IV axis 1 disorders, patient edition (SCID-P), version 2. Psychiatric Institute, Biometrics Research, New York.
7. S. Gershon, and J.C. Soares Current therapeutic profile of lithium Arch. Gen. Psychiatry 54 1997 16 20
8. J.A. Goldstein Danazol and the rapid-cycling patient (letter) J. Clin. Psychol. 47 1986 153 154
9. F.K. Goodwin, and K.R. Jamison Manic-Depressive Illness 1990 Oxford University Press New York
10. S.R. Kay, A. Fiszbein, and L.A. Opler The positive and negative syndrome scale (PANSS) for schizophrenia Schizophr. Bull. 13 1987 261 276
11. J. Kulkarni, A. Riedel, A.R. de Castella, P.B. Fitzgerald, T.J. Rolfe, J. Taffe, and H. Burger Estrogen - a potential treatment for schizophrenia Schizophr Res. 48 1 2001 137 144
12. M. Landry, D. Levesque, and T. Di Paolo Estrogenic properties of raloxifene, but not tamoxifen, on D2 and D3 dopamine receptors in the rat forebrain Neuroendocrinology 76 4 2002 214 222
13. H.K. Manji, and R.H. Lenox Protein Kinase C signalling in the brain: molecular transduction of mood stabilization in the treatment of manic-depressive illness Biol. Psychiatry 46 1999 1328 1351
14. R. O'Regan, and V. Jordan The evolution of tamoxifen therapy in breast cancer and selective estrogen - receptor modulators and down regulators Lancet Oncol. 3 2002 207 214
15. C.A. Singer, K.L. Rogers, T.M. Strickland, and D.M. Dorsa Estrogen protects primary cortical neurons from glutamate toxicity Neurosci. Lett. 212 1996 13 16